The largest database of trusted experimental protocols

Kifunensine

Manufactured by LGC
Sourced in Canada

Kifunensine is a laboratory reagent that functions as an alpha-mannosidase inhibitor. It is used in research applications to study glycosidase enzyme activity and cell biology processes involving glycoprotein biosynthesis and trafficking.

Automatically generated - may contain errors

4 protocols using kifunensine

1

HCV E1 Protein Purification and Deglycosylation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The N43Q mutant construct was transiently expressed in HEK 293T cells in the presence of 5 μM of the N-glycosylation inhibitor kifunensine (Toronto Research Chemicals, North York, ON, Canada). The cell media, containing the secreted HCV E1, was harvested 4 days after transfection after centrifugation at 5,000 g at 15 °C for 20 min to remove debris. The media was filtered and incubated with Ni2+-charged resin (FF Chelating Sepharose resin, GE Healthcare) in a shaking incubator for 90 min at 15 °C. The resin was separated from the media, washed with 15 mM Tris-HCl pH 8.0, 0.1 M NaCl, 20 mM imidazole and the bound protein was eluted with the same buffer but containing 250 mM imidazole. To remove the C-terminal His-tag and to deglycosylate the protein, the eluted protein was incubated overnight at 22 °C with recombinant TEV protease and endoglycosidase F1 produced inhouse. The supernatant was filtered and the protein purified by size-exclusion chromatography in 20 mM Tris-HCl pH 7.0 and 0.1 M NaCl on a Superdex 75 column (GE Healthcare). Fractions containing pure protein (nE1) were collected and 3-(1-Pyridino)-1-propane sulphonate (NDSB 201, Soltec Ventures Inc.) was added to a final concentration of 300 mM, to enable the protein to be concentrated to between 17 and 22 mg ml−1.
+ Open protocol
+ Expand
2

TLR3 Kifunensine Treatment Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
6 h after coating, P2.1 cells with and without stable transfection of WT or P680L TLR3 were incubated with 166 µM kifunensine (Toronto Research Chemicals) for 48 h. The cells were then washed twice with cold PBS and lysed in 1% NP-40 lysis buffer, then subjected to SDS-PAGE for immunoblotting.
+ Open protocol
+ Expand
3

Recombinant MUC2-C Production and Purification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Using the NovaCHOice transfection kit (Merck Millipore), the recombinant MUC2-C expression vector was transiently transfected into CHO-S cells growing in 800 ml flasks and FreeStyle CHO growth medium (Gibco) without serum. The extracellular recombinantly expressed protein was collected 72 h after the transfection by centrifuging the cell media at 500 × g and 6000 × g and discarding the cell pellet. To obtain the high-mannose recombinant MUC2-C the expression was done in presence of 1 μg/ml kifunensine (Toronto Research Chemicals).
The recombinant protein was purified from the supernatant by Immobilized metal affinity chromatography (IMAC) method using Ni-Sepharose® Excel (Cytiva) in a loaded gravity column (BioRad). The loaded resin was washed with 300 mM NaCl, 20 mM HEPES pH 7.4 and 40 mM imidazole, and the protein was eluted with 300 mM NaCl, 20 mM HEPES pH 7.4 and 300 mM imidazole. For the high-mannose MUC2-C the elution was dialyzed over-night against 150 mM NaCl, 20 mM MES, pH 5.5, and treated with EndoH (Roche) glycosidase at 4 °C. The products were then purified by Size Exclusion Chromatography (SEC) using an Äkta HPLC system (GE Healthcare) with a HiLoad 16/600 Superdex 200 column (GE Healthcare) in 150 mM NaCl, 20 mM HEPES, pH 7.4.
+ Open protocol
+ Expand
4

Purification of N-terminal Flag-tagged ABCG2 from HEK293 cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human full-length ABCG2 (Uniprot: Q9UNQ0), containing an N-terminal Flag tag, was expressed in HEK293-EBNA cells as previously described 49 . The cells were treated with 5 μM kifunensine (Toronto Research Chemicals) for 30 min prior to transfection. Following transfection the cells were incubated for 2 days at 37 °C before harvesting.
Transfected cells were solubilized in 40 mM HEPES pH 7.5, 150 mM NaCl, 10% v/v glycerol, 1 mM PMSF, 2 μg mL -1 DNaseI (Roche) and protease inhibitor cocktail (Sigma) with 1% DDM + 0.1% CHS (w/v) (Anatrace) for 90 min at 4 °C. The solubilized lysate was ultracentrifuged at 100,000g and the supernatant was incubated with anti-Flag M2 affinity agarose gel (Sigma). The gel was washed extensively with purification buffer containing 40 mM HEPES pH 7.5, 150 mM NaCl and 0.026% DDM + 0.0026% CHS (w/v). ABCG2 was eluted with Flag peptide (Sigma) and treated with EndoF before being loaded into a TSKgel G3000SWXL column (Tosoh Bioscience).
The peak fractions were collected and reconstituted into nanodiscs or liposomes and used for either cryo-EM studies or functional assays.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!